KITE Kite Pharma, Inc.

Kite Pharma, Inc. (Nasdaq:KITE) today announced that management will host a conference call and live webcast discussion at 4:30 p.m. Eastern Time on Thursday, November 12, 2015, to discuss financial results for the third quarter ended September 30, 2015, and provide a business update.

To access the live conference call via phone, please dial (844) 856-8656. International callers may access the live call by dialing (443) 877-4062. The conference ID number for the live call is 57896657.

The live and archived webcast can be accessed through the Calendar of Events section of the Company's website at ir.kitepharma.com. Please log in approximately 5-10 minutes prior to the event to register and to download and install any necessary software. A replay of the webcast will be available on the Company's website for two weeks following the event.

About Kite Pharma

Kite Pharma, Inc., is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a primary focus on engineered autologous cell therapy (eACT™) designed to restore the immune system's ability to recognize and eradicate tumors. Kite is based in Santa Monica, CA. For more information on Kite Pharma, please visit www.kitepharma.com. Sign up to follow @KitePharma on Twitter at www.twitter.com/kitepharma.

CONTACT: Kite Pharma
         Cynthia M. Butitta
         Chief Financial Officer and Chief Operating Officer
         310-824-9999
         
         For Media: Justin Jackson
         For Investor Inquiries: Lisa Burns
         Burns McClellan
         212-213-0006
         jjackson@burnsmc.com
         lburns@burnsmc.com